BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 23403334)

  • 1. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus.
    Puntmann VO; D'Cruz D; Smith Z; Pastor A; Choong P; Voigt T; Carr-White G; Sangle S; Schaeffter T; Nagel E
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):295-301. PubMed ID: 23403334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus.
    Zhang Y; Corona-Villalobos CP; Kiani AN; Eng J; Kamel IR; Zimmerman SL; Petri M
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):389-97. PubMed ID: 25352245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus.
    Mavrogeni S; Koutsogeorgopoulou L; Markousis-Mavrogenis G; Bounas A; Tektonidou M; Lliossis SC; Daoussis D; Plastiras S; Karabela G; Stavropoulos E; Katsifis G; Vartela V; Kolovou G
    Lupus; 2018 Apr; 27(4):564-571. PubMed ID: 28927316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The apparent diffusion coefficient is strongly correlated with extracellular volume, a measure of myocardial fibrosis, and subclinical cardiomyopathy in patients with systemic lupus erythematosus.
    Wu R; An DA; Hu J; Jiang M; Guo Q; Xu JR; Wu LM
    Acta Radiol; 2018 Mar; 59(3):287-295. PubMed ID: 28679323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach.
    Abdel-Aty H; Siegle N; Natusch A; Gromnica-Ihle E; Wassmuth R; Dietz R; Schulz-Menger J
    Lupus; 2008 Jun; 17(6):561-7. PubMed ID: 18539710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Detection of Silent Myocardial Impairment in Drug-Naive Patients With New-Onset Systemic Lupus Erythematosus: A Three-Center Prospective Study.
    Guo Q; Wu LM; Wang Z; Shen JY; Su X; Wang CQ; Gong XR; Yan QR; He Q; Zhang W; Xu JR; Jiang M; Pu J
    Arthritis Rheumatol; 2018 Dec; 70(12):2014-2024. PubMed ID: 30070061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy.
    McLellan AJ; McKenzie SC; Taylor AJ
    Heart Lung Circ; 2012 Jan; 21(1):30-5. PubMed ID: 22055931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis.
    Mavrogeni S; Bratis K; Markussis V; Spargias C; Papadopoulou E; Papamentzelopoulos S; Constadoulakis P; Matsoukas E; Kyrou L; Kolovou G
    Lupus; 2013 Jan; 22(1):34-43. PubMed ID: 23035042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1-Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema.
    Ntusi N; O'Dwyer E; Dorrell L; Wainwright E; Piechnik S; Clutton G; Hancock G; Ferreira V; Cox P; Badri M; Karamitsos T; Emmanuel S; Clarke K; Neubauer S; Holloway C
    Circ Cardiovasc Imaging; 2016 Mar; 9(3):e004430. PubMed ID: 26951605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial fibrosis associates with lupus anticoagulant in patients with systemic lupus erythematosus.
    Myhr KA; Zinglersen AH; Pecini R; Jacobsen S
    Int J Cardiovasc Imaging; 2024 Jan; 40(1):127-137. PubMed ID: 37814154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of Q waves in II, III, avF in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance imaging.
    Mavrogeni S; Bratis K; Kolovou G
    Lupus; 2012 Jul; 21(8):821-9. PubMed ID: 22422802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-tesla magnetic resonance imaging.
    Tyan CC; Armstrong S; Scholl D; Stirrat J; Blackwood K; El-Sherif O; Thompson T; Wisenberg G; Prato FS; So A; Lee TY; Drangova M; White JA
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):229-38. PubMed ID: 23413422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myocardial involvement in 2494 patients with systemic lupus erythematosus].
    Qi LP; Zhang W; Yan XW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Apr; 36(4):317-9. PubMed ID: 19100007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients With Sarcoidosis and Preserved Left Ventricular Ejection Fraction.
    Greulich S; Kitterer D; Latus J; Aguor E; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Mayr A; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis.
    Lee SP; Lee W; Lee JM; Park EA; Kim HK; Kim YJ; Sohn DW
    Radiology; 2015 Feb; 274(2):359-69. PubMed ID: 25251584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging.
    Barison A; Aquaro GD; Pugliese NR; Cappelli F; Chiappino S; Vergaro G; Mirizzi G; Todiere G; Passino C; Masci PG; Perfetto F; Emdin M
    J Intern Med; 2015 May; 277(5):605-14. PubMed ID: 25346163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial injury in systemic lupus erythematosus according to cardiac magnetic resonance tissue characterization: clinical and echocardiographic features.
    du Toit R; Herbst PG; Ackerman C; Pecoraro AJ; du Toit RH; Hassan K; Joubert LH; Reuter H; Doubell AF
    Lupus; 2020 Oct; 29(11):1461-1468. PubMed ID: 32631204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
    Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.